N/A N=56 Enhanced Recovery After Spine Surgery
Enhanced Recovery After Surgery · Spine Surgery
Primary: Patient Score on QoR40 Inventory. — 179.4; 170.3 scores on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=118 Enhanced Recovery at Cesarean Birth to Improve Postoperative Outcomes and Reduce Postoperative Length of Stay
Cesarean Section
Primary: Discharge on Postoperative Day #2 — 5; 2 Participants
N/A N=541 Cesarean Section Via Enhanced Recovery
Cesarean Section
Primary: Opioid Consumption — 60.34; 104.33 oral morphine equivalents (mg) — p=< 0.001
N/A N=101 Implementing Enhanced Recovery After Surgery (ERAS) Pathways In Major Gynecologic Oncology Operations In Greece
Ovarian Cancer · Hysterectomy · Endometrial Cancer
Primary: Length of Hospital Stay (LOS) — 3.8; 5.9 days
Phase 4 N=109 Prospective Randomized Controlled Trial of an Enhanced Recovery Protocol for Anorectal Surgery
Anorectal Disorder
Primary: Total Narcotic Use Postoperatively in Oral Morphine Equivalents — 8; 79 Oral morphine miligram equivalents
Phase 3 N=3,395 Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data
Perioperative Optimization
Primary: 30 Day Hospital Free Days — 27; 27; 26; 27 Number of hospital free days
N/A N=100 A Trial of Adding Lung Protective Strategies to Existing Enhanced Recovery After Surgery (ERAS) Protocols and Its Effects on Improving Post-Operative Lung Function
Colorectal Surgery · Hepatobiliary Surgery
Primary: Inspiratory Capacity — 2,043.3; 2,012.2; 1,195.2; 1,233.3 mL
Phase 4 N=44 Pudendal Enhancement of Enhanced Recovery After Surgery (ERAS) for Reconstructive Surgery (PEERS)
Pain Management
Primary: Narcotic Use — 8; 6.75 MME
N/A N=274 Intermountain Healthcare's Enhanced Recovery Protocol for Colon Surgery With and Without Alvimopan Use
Ileus
Primary: Measure of Improvement Over the Standard — 4.97; 3.98 Days in the hospital
Early Phase 1 N=103 Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Cervical Cancer · Uterine Endometrial Cancer · Ovarian Cancer
Primary: Hospital Stay — 3.0; 3.0 Days — p=0.36
N/A N=455 Safety of Total Knee Replacement Surgery Before and After the Implementation of Enhanced Recovery Program
Arthroplasty Complications
Primary: Number of Patients With Early Complication — 9; 16; 4 Participants
Phase 3 N=104 Epidural Anesthesia Within an Enhanced Recovery Pathway in Reducing Pain in Patients Undergoing Gynecologic Surgery
Intraoperative Complication · Malignant Female Reproductive System Neoplasm · Pain
Primary: Relative Pain Scores, as Measured by the Pain Numeric Rating Scale (NRS) — 3.87; 4.95 score on a scale
Phase 4 N=46 Erector Spinae Plane Block Versus Conventional Analgesia in Complex Spine Surgery
Opioid Use · Pain, Postoperative
Primary: Intraoperative and Postoperative Opioid Consumption — 191; 139.4 MME/day
N/A N=77 Accelerated Recovery Pathway for Discharge After Surgery in Patients With Pancreatic Cancer
Pancreatic Carcinoma
Primary: Percentage of Patients Discharged by Post-operative Day 5 — 5; 28 Participants
N/A N=107 Fast-track Surgery After Gynecological Oncology Surgery
Length of Stay · Postoperative Complications · CRP
Primary: Length of Hospitalization Post-operation — 8.92; 9.67 days — p=0.141
N/A N=198 Fast-track Rehabilitation After Elective Colorectal and Small Bowel Resection
Colorectal Tumor
Primary: the Length of Hospital Stay — 8; 7 day
N/A N=97 Low Pressure Pneumoperitoneum and Deep Neuromuscular Block vs. Standard During RARP to Improve Quality of Recovery; a Randomized Controlled Study.
Quality of Life · Postoperative Complications · Acute Pain
Primary: Quality of Recovery - 40 Items Questionnaire Score (QoR-40) — 162.7; 167.6 score on a scale of 200 — p=0.54
N/A N=174 Expectations and Pain Control Advancement In surgeRy: The REPAIR Trial
Abuses Over-The-Counter/Prescription Medications · Pain, Postoperative · Opioid Use
Primary: Opioid Use at Approximately Two Weeks Post-op — 15; 22.5 MME
Phase 4 N=1,570 The Impact of Perioperative Ketamine Infusion on Surgical Recovery
Opioid Use · Enhanced Recovery After Surgery · Anesthesia
Primary: Length of Stay — 5.0; 5.0 days
Phase 4 N=180 IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population
Abdominal Wall Hernia · Pancreatic Diseases · Bowel Disease
Primary: Postoperative Pain Intensity — 33; 42 Participants
N/A N=60 Perianastomotic Drain After Gastrectomy (DRAG)
Gastric Cancer
Primary: a) Number of Participants With High Pain Levels (Using the Visual Analog Scale) — 31; 3 Participants
Phase 4 N=48 Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty
Pain, Postoperative · Urethral Stricture
Primary: Participant Pain Control: Numerical Rating Scale (NRS) — 1.2; .625 score on a scale
N/A N=128 Epidural Analgesia (EDA) Versus Patient Controlled Analgesia (PCA) in Laparoscopic Colon Surgery
Laparoscopic Colectomy
Primary: Medical Recovery (Defined as Pain Sufficient Controlled by Oral Analgesia, Fully Mobile Patients or at Least as Mobile as at Admission and Tolerance of the Patient of…
N/A N=200 Efficacy Safety Score in Postoperative Management
Pain, Postoperative · Postoperative Nausea and Vomiting
Primary: Time to Mobilization — 10.1; 14.2 hours
Phase 4 N=350 Deep Neuromuscular Block for Laparoscopic Surgery
Laparoscopy · Anesthesia Recovery Period
Primary: Percentage of Patients Recovered Cognitively at 1 Week — 91.8; 92.9 percentage of patients recovered
Phase 3 N=146 Accelerating Gastrointestinal Recovery
Ovarian Cancer · Fallopian Tube Cancer · Peritoneal Cancer
Primary: Postoperative Length of Hospital Stay — 4.4; 4.3 days — p=0.34
Phase 4 N=45 Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management
Postoperative Pain
Primary: Analgesic Requirement — 0.60 (mg/kg)
N/A N=130 Comparison Between End-to-side and Side-to-side Anastomosis After Laparoscopic Right Hemicolectomy
Anastomosis
Primary: Cumulative Recovery Rate — 100; 100 percentage of participants
Phase 4 N=120 Sugammadex To IMprove Bowel Function
Bowel Dysfunction · Postoperative Complications · Neuromuscular Blockade
Primary: Gastric Emptying — 1120; 1130 log(ng*ml-1)*min — p=0.58
N/A N=1,152 Efficacy Side-effect Score (ESS): Development and Evaluation of a New Tool for Patients After Surgery
Postoperative Pain · Postoperative Vomiting and Nausea · Postoperative Complications
Primary: Length of Hospital Stay (LOS) — 12.7; 13.5; 14.2 days